Regor

Pre-clinical target discovery, validation, and optimization - Regor Therapeutics Group

Cambridge, United States · $90.0M raised

Headquarters
Cambridge
Business Model
B2B
Website
regor.com
Total Funding
$90.0M
Last Round
$90.0M Series BFeb 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Regor Therapeutics Group is a clinical-stage biotechnology company developing differentiated medicines for unmet needs in oncology, metabolism, and autoimmunity. Its rCARD computer-accelerated drug-discovery engine supports rapid prototyping and validation of small-molecule candidates against significant targets. Headquartered in Cambridge, Massachusetts, the company also operates in Houston, San Diego, and Shanghai and pursues partnerships around its drug candidates.

Summary

Regor is a Biotech company based in Cambridge, United States. It has raised $90.0M in total across 1 round, most recently a $90.0M Series B round in Feb 2021. Investors include Lilly Asia Ventures, Loyal Valley Capital and TF Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BFeb 2021
$90.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Regor on Indexed.vc
<a href="https://indexed.vc/companies/regor"><img src="https://indexed.vc/api/badge/company/regor" alt="Regor on Indexed.vc" width="260" height="76" /></a>